GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
Recruiting
- Conditions
- Gastric Content Aspiration
- Interventions
- Other: Esophagogastroduodenoscopy
- Registration Number
- NCT05875636
- Lead Sponsor
- Medical University of South Carolina
- Brief Summary
This study will enroll patients ages 18 and over who are in one of the following groups 1) taking a GLP-1 receptor agonist medication 2) not taking a GLP-1 receptor agonist (control group), are undergoing EGS and have appropriately fasted. Study data will be collected in the form of qualitatively observing whether the stomach is empty as expected, or contains solid or clinically relevant liquid contents.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 260
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients taking a GLP-1 agonist medication Esophagogastroduodenoscopy Participants meeting all inclusion/exclusion criteria who are taking a GLP-1 agonist medication Controls Esophagogastroduodenoscopy Participants meeting all inclusion/exclusion criteria and are NOT taking a GLP-1 agonist medication.
- Primary Outcome Measures
Name Time Method Retained gastric food From time of enrollment until the end of surgery, assessed up to 4 weeks Incidence of clinically significant retained gastric food, defined as visible solid/particulate matter, or liquid volume \> 1.5cc/kg
- Secondary Outcome Measures
Name Time Method Incidence of pulmonary aspiration event From the time surgery begins until the end of scheduled surgery, assessed up to 24 hours
Trial Locations
- Locations (1)
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States